Department of Ophthalmology, Medical Faculty Mannheim, Ruprecht-Karls-University Heidelberg , Mannheim , Germany.
Division of Geriatric Psychiatry, Central Institute of Mental Health, Medical Faculty Mannheim, Ruprecht-Karls-University Heidelberg , Mannheim , Germany.
Front Neurol. 2013 Dec 16;4:203. doi: 10.3389/fneur.2013.00203. eCollection 2013.
Alzheimer's disease (AD) is a long term progressive neurodegenerative disease and might affect the retinal nerve fiber layer thickness (RNFLT) of the eye. There is increasing evidence that visual evoked potentials (VEP), which are an objective way to indicate visual field loss, might be affected by the disease as well.
About 22 patients (mean age: 75.9 ± 6.1 years; 14 women) with mild-to-moderate AD and 22 sex-matched healthy patients were examined. We compared the use of VEP and RNFLT using the latest high-resolution spectral domain optical coherence tomography with eye-tracking capabilities for optimized peripapillary scan centering for the first time in AD patients.
The mean MMSE score was 22.59 ± 5.47 in the AD group, and did not significantly correlate with the VEP latencies. We found no significant difference between the VEP latencies of the AD patients and those of the control patients. No peripapillary sector of the retina had a RNFLT significantly correlated with the VEP latencies.
We demonstrated that pattern VEP did not show any significant correlation despite subtle loss in RNFLT. It remains open whether additional flash VEP combined with RNFLT analysis may be useful in diagnosing AD, particularly for mild-to-moderate stages of the disease.
阿尔茨海默病(AD)是一种长期的进行性神经退行性疾病,可能会影响眼睛的视网膜神经纤维层厚度(RNFLT)。越来越多的证据表明,视觉诱发电位(VEP)作为一种客观的视野丧失指标,也可能受到该疾病的影响。
我们对大约 22 名(平均年龄:75.9±6.1 岁;14 名女性)轻度至中度 AD 患者和 22 名性别匹配的健康患者进行了检查。我们首次使用具有眼部跟踪功能的最新高分辨率谱域光学相干断层扫描技术,比较了 VEP 和 RNFLT 的使用情况,以优化视盘周围扫描的中心定位。
AD 组的 MMSE 评分平均为 22.59±5.47,与 VEP 潜伏期无显著相关性。我们发现 AD 患者与对照组患者的 VEP 潜伏期没有显著差异。视网膜的任何视盘周围扇形区域的 RNFLT 均与 VEP 潜伏期无显著相关性。
尽管 RNFLT 有轻微损失,但我们证明模式 VEP 没有显示出任何显著的相关性。额外的闪光 VEP 结合 RNFLT 分析是否可用于诊断 AD,特别是在疾病的轻度至中度阶段,仍有待探讨。